Biomarin Pharmaceutical Inc (BMRN) SEC News Jan. 12, 2026, 21:44 UTC (70% Positive) Biomarin Pharmaceutical Inc (BMRN) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 6:56 p.m. 📋 Biomarin Pharmaceutical Inc (BMRN) - Financial Results Filing Date: 2026-01-12 Accepted: 2026-01-12 16:44:35 Event Type: Financial Results Event Details: Biomarin Pharmaceutical Inc (BMRN) Reports the reporting period Financial Results Biomarin Pharmaceutical Inc (BMRN) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $120 Net Income: $120 EPS: Not disclosed Cash and equivalents: Not disclosed 📊 Key Financial Metrics: Metric Value Revenue $120 Net Income $120 💼 Business Developments: Partnership: Not availableAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Biomarin Pharmaceutical IncTicker Symbol: BMRN
📋 Biomarin Pharmaceutical Inc (BMRN) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 16:44:35
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: